Enhanced production of platelet-activating factor in stimulated rat leukocytes pretreated with triacsin C, A novel acyl-coA synthetase inhibitor

Biochem Biophys Res Commun. 1992 Nov 16;188(3):1280-5. doi: 10.1016/0006-291x(92)91370-6.

Abstract

Triacsin C, a product of Streptmyces sp. SK-1894, was previously reported as an inhibitor of long chain acyl-CoA synthetase. Pretreatment with triacsin C (500 nM) for 1h enhanced production of platelet-activating factor in rat neutrophils, followed by stimulation with A23187 or fMLP. Amount of lyso-PAF was also augumented. Triacsin C alone did not increase PAF content and did not modulate enzymatic activities of acytransferase, cholinephosphotransferase, acetylhydrolase, acetyltransferase or phospholipase A2. These results suggest that triacsin C might enhance supply of substrate for PAF synthesis, i.e. accumulation of lyso-PAF by interfering reacylation pathway.

MeSH terms

  • Acylation
  • Animals
  • Calcimycin / pharmacology
  • Coenzyme A Ligases / antagonists & inhibitors*
  • Male
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • Neutrophils / drug effects
  • Neutrophils / metabolism*
  • Platelet Activating Factor / analogs & derivatives
  • Platelet Activating Factor / biosynthesis*
  • Rats
  • Rats, Sprague-Dawley
  • Repressor Proteins*
  • Saccharomyces cerevisiae Proteins*
  • Triazenes / pharmacology*

Substances

  • O-deacetyl platelet activating factor
  • Platelet Activating Factor
  • Repressor Proteins
  • Saccharomyces cerevisiae Proteins
  • Triazenes
  • Calcimycin
  • N-Formylmethionine Leucyl-Phenylalanine
  • triacsin C
  • Coenzyme A Ligases
  • FAA2 protein, S cerevisiae
  • long-chain-fatty-acid-CoA ligase